Login
$TYRA
$19.74 -$0.29 (1.42%) Live

Company Executives

Officer Age In this role 2025 pay Source
Todd Harris Also a director
President, Chief Executive Officer and Director
46 Not stated $5,566,997
Alan Fuhrman
Chief Financial Officer
69 Since 2023
3 years
Not reported
Bhavesh Ashar
Chief Operating Officer
57 Since 2025
1 year
$4,685,274
Douglas Warner
Chief Medical Officer
54 Since 2024
2 years
$2,372,243
Yuliya Rueb
Vice President, Finance (PAO)
Title from the Form 4 dated Sep 15, 2026
Not stated Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
10
serving now
Independent
9 of 10
stated in the proxy
Average tenure
4.1 years
from year joined
CEO also chairs the board
No
Robert More
Director Age On board Independent Committees Other public boards 2025 pay Source
Robert More
58 2018
8 years
Independent
Audit Nominating and Corporate Governance · Chair
Vir Biotechnology, Inc. $232,670
Todd Harris, Ph.D.
46 2018
8 years
Not independent None stated None stated Paid as CEO
Habib J. Dable
56 2026
this year
Independent None stated Spyglass Pharma, Inc. Not stated
Susan Moran, M.D., M.S.C.E.
56 2024
2 years
Independent
Compensation · Chair Science and Technology
None stated $203,272
Melissa McCracken, Ph.D.
39 2021
5 years
Independent
Audit Science and Technology
Alterome Therapeutics, Inc., Airna, Inc., Ambagon Therapeutics, Inc., Alpha-9 Oncology, K36 Therapeutics, Inc. Not stated
Jake Simson, Ph.D.
40 2020
6 years
Independent
Nominating and Corporate Governance Science and Technology · Chair
Janux Therapeutics, Inc. $203,535
Rehan Verjee
45 2021
5 years
Independent
Audit · Chair Compensation
None stated $205,570
Adele M. Gulfo
63 2025
1 year
Independent
Compensation
New Amsterdam Pharma Co N.V., Enpro Inc. $553,721
S. Michael Rothenberg, M.D., Ph.D.
56 2024
2 years
Independent
Science and Technology
None stated $192,465
Gilla Kaplan, Ph.D. Leaving at the meeting
Not stated Not stated Independent
Nominating and Corporate Governance Science and Technology
None stated $197,057

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 17, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support